Investigating treat-to-target low-density lipoprotein-choles

In a recent study published in JAMA, researchers investigated whether treat-to-target (TTT) low-density lipoprotein-cholesterol (LDL-C) therapy was inferior to administering statins of high intensity for clinical outcomes in the long term among coronary artery disease (CAD) patients.

Related Keywords

United States , American , , Image Credit , High Intensity Statin , Patients With Coronary Artery Disease , Randomized Clinical , Discovery Industry Focus , Cholesterol , Oronary Artery Disease , Ipoprotein , Cute Coronary Syndrome , Angina , Linical Trial , Creatine , Iabetes , Eart , Eart Disease , Schemic Heart Disease , Inase , Yocardial Infarction , Renal Disease , Statin , Troke , Yndrome ,